30 Spam-Free Article(s) Found
Sort:
Relevance
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
ABT Abbott Laboratories $67.67 $118.71B N/A
Article Searches
Solid Sales Growth Makes These 5 Stocks Worth Buying Now http://www.zacks.com/stock/news/399339/solid-sales-growth-makes-these-5-stocks-worth-buying-now?cid=CS-ZC-FT-399339 Apr 25, 2019 - Sales growth is an early indicator of the company's future earnings performance.
Omnicell (OMCL) Earnings and Revenues Beat Estimates in Q1 http://www.zacks.com/stock/news/404289/omnicell-omcl-earnings-and-revenues-beat-estimates-in-q1?cid=CS-ZC-FT-404289 Apr 26, 2019 - Omnicell (OMCL) gains from solid segmental contributions in Q1; margins expand.
GNC Holdings (GNC) Reports Q1 Earnings, Revenues Down Y/Y http://www.zacks.com/stock/news/404443/gnc-holdings-gnc-reports-q1-earnings-revenues-down-y-y?cid=CS-ZC-FT-404443 Apr 26, 2019 - Despite year-over-year decline in earnings and revenues, better performing International segment and key developments favor GNC Holdings (GNC) in Q1.
Illumina (ILMN) Q1 Earnings Beat Estimates, Gross Margin Up http://www.zacks.com/stock/news/404475/illumina-ilmn-q1-earnings-beat-estimates-gross-margin-up?cid=CS-ZC-FT-404475 Apr 26, 2019 - Illumina's (ILMN) NextSeq and MiSeq placements witness year-over-year growth, with the strength of the former being driven by solid demand for TSO500.
Zimmer Biomet's (ZBH) Q1 Earnings, Revenues Beat Estimates http://www.zacks.com/stock/news/404555/zimmer-biomets-zbh-q1-earnings-revenues-beat-estimates?cid=CS-ZC-FT-404555 Apr 26, 2019 - While sales in Americas remains dull, Zimmer Biomet (ZBH) is witnessing strength in the Asia Pacific and EMEA regions.
Top Ranked Income Stocks to Buy for April 29th http://www.zacks.com/commentary/405059/top-ranked-income-stocks-to-buy-for-april-29th?cid=CS-ZC-FT-405059 Apr 29, 2019 - Top Ranked Income Stocks to Buy for April 29th
Chemed (CHE) Q1 Earnings Miss Estimates, Revenues Grow Y/Y http://www.zacks.com/stock/news/405943/chemed-che-q1-earnings-miss-estimates-revenues-grow-y-y?cid=CS-ZC-FT-405943 Apr 30, 2019 - Despite several downsides, Chemed (CHE) witnesses solid revenue growth across key subsidiaries - VITAS and Roto-Rooter.
Tandem's (TNDM) Q1 Loss Wider Than Expected, Sales Top Mark http://www.zacks.com/stock/news/406770/tandems-tndm-q1-loss-wider-than-expected-sales-top-mark?cid=CS-ZC-FT-406770 May 01, 2019 - Tandem's (TNDM) introduction of t:slim X2 with Basal-IQ technology, ramped-up supply capacity along with its global launch, substantially drive its top line in Q1.
ABIOMED (ABMD) Q4 Earnings Meet Estimates, Sales Rise in Japan http://www.zacks.com/stock/news/407593/abiomed-abmd-q4-earnings-meet-estimates-sales-rise-in-japan?cid=CS-ZC-FT-407593 May 02, 2019 - ABIOMED's (ABMD) Q4 results gain from solid Impella show in Japan.
Amedisys (AMED) Tops Earnings and Revenue Estimates in Q1 http://www.zacks.com/stock/news/407597/amedisys-amed-tops-earnings-and-revenue-estimates-in-q1?cid=CS-ZC-FT-407597 May 02, 2019 - At Home Health and Hospice divisions, Amedisys (AMED) witnesses solid year-over-year growth in Medicare and non-Medicare revenues.

Pages: 123

Page 1>